
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check the tuberculosis work-up before the bronchiectasis diagnosis, the decision that long-term prescribed morphine with physiological dependence is not opioid use disorder, the voluntary taper, the prolonged grief disorder diagnosis and the safety plan, and DXA in a premenopausal woman. | ||
| provenance review | not_started | The EBB Archive chronology, the Victorian Web timeline, Kenyon's 1897 edition of the letters and the 1899 courtship letters (Project Gutenberg), a Penn State news release, and two peer-reviewed abstracts logged. The British Library, the Poetry Foundation, Britannica and the Browning Guide refused automated access or could not be found; Young's 1989 BMJ paper and Dally's 1993 paper were not read. | ||
| safe messaging review | not_started | Claims about opium, grief and proposed psychiatric explanations are marked sensitive. The record states that the evidence shows long-term prescribed use with physiological dependence and does not support a diagnosis of addiction. No self-harm is inferred. Her death is recorded in one sentence. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-10-19 Progress note 07 (C-CDA) | PHQ-9 | At least monthly during active treatment (CMID) | Missed: no PHQ-9 was recorded between the June visit and today, although the protocol calls for one at least monthly during active treatment. No harm judging by the PHQ-2 of 1 at the July preventive visit, the stable mood at the August sick visit, and today's PHQ-9 of 5. Corrective action: the psychologist's session scores are now entered in the chart, and a monthly PHQ-9 is sent through the patient portal |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-03-23 Progress note 02 (C-CDA) | Laboratory | Mycobacterial culture including nontuberculous mycobacteria | Ordered | Cultures from the three samples in progress |
| 2026-03-23 Progress note 02 (C-CDA) | Self-management | Airway clearance technique and exercise | Ordered | Physiotherapy teaching session booked this week |
| 2026-04-20 Progress note 03 (C-CDA) | Laboratory | Mycobacterial culture including nontuberculous mycobacteria | Ordered | No growth at four weeks; final at eight weeks |
| Claim | Statement | Certainty |
|---|---|---|
| CLM-0020 | Buchanan and Weiss argued in 2011 that her lifelong illness, with weakness, palpitations and sensitivity to heat and cold from adolescence, strongly suggests hypokalemic periodic paralysis. | possible |
| CLM-0021 | Conjectures by modern biographers about her illness have included anorexia nervosa, neurasthenia, tuberculosis, scoliosis, opium addiction and mental illness. | disputed |
| CLM-0022 | Quirarte-Ruvalcaba argued in 2024 that her illness was probably a congenital malformation of the lung (pulmonary sequestration) undiagnosed in her time, reassessed the possibility of morphine dependence, and suggested that an accidental morphine overdose may have contributed to her death. | possible |
| Claim | Grade | Statement |
|---|---|---|
| CLM-0004 | D | After the illness of 1821 she took opium by medical prescription, developing a lifelong habit. |
| CLM-0007 | D | On 11 July 1840 her brother Edward and two friends went sailing and did not return; the bodies were found three days later after a boat foundered in Babbacombe Bay. Her first editor wrote that she had the misery of thinking it was to attend on her that he had come to Torquay, that the place became a memory from which she shrank, and that even the sound of the sea became a horror to her. |
| CLM-0013 | D | In October 1845 she wrote to Mrs. Martin that she had been told one lung was very slightly affected but her nervous system 'absolutely shattered', that she was in the habit of taking forty drops of laudanum a day and, as the medical man told her, could not do with less, and that two physicians, Dr. Chambers among them, advised a winter in Pisa. |
| CLM-0014 | D | In a letter postmarked 15 November 1845 she told Robert Browning that her opium kept 'the pulse from fluttering and fainting', that she did not take it for her spirits, and that she suffered none of the usual effects, not even an opium headache. |
| CLM-0015 | D | In a letter postmarked 5 February 1846 she wrote that, for restlessness, loss of sleep, weakness and palpitation, 'the medical people gave me opium—a preparation of it, called morphine, and ether'; that she had never increased upon the prescribed quantity; that Mr. Jago said it would be dangerous to leave it off except very slowly and gradually; and that she would try to do with less. |
| CLM-0016 | D | In the summer of 1845 the physicians advised a warm climate for the winter; she wished to go to Pisa, but the plan was given up after her father's opposition, which she called one of the most painful griefs of her life. |
| CLM-0021 | R | Conjectures by modern biographers about her illness have included anorexia nervosa, neurasthenia, tuberculosis, scoliosis, opium addiction and mental illness. |
| CLM-0022 | R | Quirarte-Ruvalcaba argued in 2024 that her illness was probably a congenital malformation of the lung (pulmonary sequestration) undiagnosed in her time, reassessed the possibility of morphine dependence, and suggested that an accidental morphine overdose may have contributed to her death. |
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-03-16 | C-reactive protein | 8.4 mg/L (high) | High |
| 2026-03-16 | 25-hydroxyvitamin D | 15 ng/mL (low) | Low |
| 2026-03-23 | FEV1 after bronchodilator | 2.02 L (low) | Low |
| 2026-03-23 | FEV1 percent predicted after bronchodilator | 74% (low) | Low |
| 2026-03-23 | FEV1/FVC after bronchodilator | 0.69 (low) | Low |
| 2026-08-10 | C-reactive protein | 38 mg/L (high) | High |
| 2026-08-10 | White cell count | 11.8 10*3/uL (high) | High |